Skip to main content
Top
Published in:

03-01-2024 | Editorial

Pituitary: hic manebimus optime

Author: Andrea Giustina

Published in: Pituitary | Issue 1/2024

Login to get access

Excerpt

This is my first Editorial as Editor-in-Chief of Pituitary, and it is my pleasure and honour to welcome all the old and new readers of the journal which I am sure will either continue to be or become, the common house for discussing and enjoying the latest advances in basic and clinical pituitary science. …
Literature
1.
go back to reference Melmed S A fond farewell Pituitary in press Melmed S A fond farewell Pituitary in press
5.
go back to reference Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21(4):667–678. https://doi.org/10.1007/s11154-020-09588-z. Epub 2020 Sep 10. PMID: 32914330; PMCID: PMC7942783CrossRefPubMedPubMedCentral Giustina A, Barkhoudarian G, Beckers A, Ben-Shlomo A, Biermasz N, Biller B, Boguszewski C, Bolanowski M, Bollerslev J, Bonert V, Bronstein MD, Buchfelder M, Casanueva F, Chanson P, Clemmons D, Fleseriu M, Formenti AM, Freda P, Gadelha M, Geer E, Gurnell M, Heaney AP, Ho KKY, Ioachimescu AG, Lamberts S, Laws E, Losa M, Maffei P, Mamelak A, Mercado M, Molitch M, Mortini P, Pereira AM, Petersenn S, Post K, Puig-Domingo M, Salvatori R, Samson SL, Shimon I, Strasburger C, Swearingen B, Trainer P, Vance ML, Wass J, Wierman ME, Yuen KCJ, Zatelli MC, Melmed S (2020) Multidisciplinary management of acromegaly: a consensus. Rev Endocr Metab Disord 21(4):667–678. https://​doi.​org/​10.​1007/​s11154-020-09588-z. Epub 2020 Sep 10. PMID: 32914330; PMCID: PMC7942783CrossRefPubMedPubMedCentral
6.
go back to reference Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A, Pituitary, Society, Expert Group on Pituitary Tumors (2017) Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 20(5):489–498 Erratum in: Pituitary. 2018;: PMID: 28884415; PMCID: PMC5606938CrossRefPubMedPubMedCentral Casanueva FF, Barkan AL, Buchfelder M, Klibanski A, Laws ER, Loeffler JS, Melmed S, Mortini P, Wass J, Giustina A, Pituitary, Society, Expert Group on Pituitary Tumors (2017) Criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 20(5):489–498 Erratum in: Pituitary. 2018;: PMID: 28884415; PMCID: PMC5606938CrossRefPubMedPubMedCentral
7.
go back to reference Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Reincke M, Strasburger C, van der Lely AJ, Wass JAH, Melmed S, Casanueva FF (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26(5):583–596. https://doi.org/10.1007/s11102-023-01345-0. Epub 2023 Aug 28. PMID: 37640885; PMCID: PMC10539196CrossRefPubMedPubMedCentral Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Reincke M, Strasburger C, van der Lely AJ, Wass JAH, Melmed S, Casanueva FF (2023) Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers. Pituitary 26(5):583–596. https://​doi.​org/​10.​1007/​s11102-023-01345-0. Epub 2023 Aug 28. PMID: 37640885; PMCID: PMC10539196CrossRefPubMedPubMedCentral
9.
go back to reference Tulipano G, Taylor JE, Halem HA, Datta R, Dong JZ, Culler MD, Bianchi I, Cocchi D, Giustina A (2007) Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125. Pituitary. ;10(3):267 – 74. https://doi.org/10.1007/s11102-007-0054-6. PMID: 17587180 Tulipano G, Taylor JE, Halem HA, Datta R, Dong JZ, Culler MD, Bianchi I, Cocchi D, Giustina A (2007) Glucocorticoid inhibition of growth in rats: partial reversal with the full-length ghrelin analog BIM-28125. Pituitary. ;10(3):267 – 74. https://​doi.​org/​10.​1007/​s11102-007-0054-6. PMID: 17587180
10.
go back to reference Tulipano G, Faggi L, Cacciamali A, Spinello M, Cocchi D, Giustina A (2014) Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro. Pituitary 17(3):203-209. https://doi.org/10.1007/s11102-013-0488-y. PMID: 23649927 Tulipano G, Faggi L, Cacciamali A, Spinello M, Cocchi D, Giustina A (2014) Interplay between the intracellular energy sensor AMP-activated protein kinase (AMPK) and the estrogen receptor activities in regulating rat pituitary tumor cell (GH3) growth in vitro. Pituitary 17(3):203-209. https://​doi.​org/​10.​1007/​s11102-013-0488-y. PMID: 23649927
11.
go back to reference De Marinis L, Bianchi A, Fusco A, Cimino V, Mormando M, Tilaro L, Mazziotti G, Pontecorvi A, Giustina A (2007) Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. Pituitary 10(3):227–232. https://doi.org/10.1007/s11102-007-0037-7. PMID: 17484056CrossRefPubMed De Marinis L, Bianchi A, Fusco A, Cimino V, Mormando M, Tilaro L, Mazziotti G, Pontecorvi A, Giustina A (2007) Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. Pituitary 10(3):227–232. https://​doi.​org/​10.​1007/​s11102-007-0037-7. PMID: 17484056CrossRefPubMed
12.
13.
go back to reference De Marinis L, Bianchi A, Mazziotti G, Mettimano M, Milardi D, Fusco A, Cimino V, Maira G, Pontecorvi A, Giustina A (2008) The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. Pituitary 11(1):13–20. https://doi.org/10.1007/s11102-007-0062-6. PMID: 17987389 De Marinis L, Bianchi A, Mazziotti G, Mettimano M, Milardi D, Fusco A, Cimino V, Maira G, Pontecorvi A, Giustina A (2008) The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. Pituitary 11(1):13–20. https://​doi.​org/​10.​1007/​s11102-007-0062-6. PMID: 17987389
14.
go back to reference Mazziotti G, Mancini T, Mormando M, De Menis E, Bianchi A, Doga M, Porcelli T, Vescovi PP, De Marinis L, Giustina A (2011) High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary 14(4):299–306. https://doi.org/10.1007/s11102-011-0293-4. PMID: 21301967 Mazziotti G, Mancini T, Mormando M, De Menis E, Bianchi A, Doga M, Porcelli T, Vescovi PP, De Marinis L, Giustina A (2011) High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. Pituitary 14(4):299–306. https://​doi.​org/​10.​1007/​s11102-011-0293-4. PMID: 21301967
18.
go back to reference Samson SL, Nachtigall LB, Fleseriu M, Gordon MB, Bolanowski M, Labadzhyan A, Ur E, Molitch M, Ludlam WH, Patou G, Haviv A, Biermasz N, Giustina A, Trainer PJ, Strasburger CJ, Kennedy L, Melmed S (2020) Maintenance of Acromegaly Control in patients switching from Injectable somatostatin receptor ligands to oral Octreotide. J Clin Endocrinol Metab 105(10):e3785–e3797. https://doi.org/10.1210/clinem/dgaa526. PMID: 32882036; PMCID: PMC7470473CrossRefPubMedPubMedCentral Samson SL, Nachtigall LB, Fleseriu M, Gordon MB, Bolanowski M, Labadzhyan A, Ur E, Molitch M, Ludlam WH, Patou G, Haviv A, Biermasz N, Giustina A, Trainer PJ, Strasburger CJ, Kennedy L, Melmed S (2020) Maintenance of Acromegaly Control in patients switching from Injectable somatostatin receptor ligands to oral Octreotide. J Clin Endocrinol Metab 105(10):e3785–e3797. https://​doi.​org/​10.​1210/​clinem/​dgaa526. PMID: 32882036; PMCID: PMC7470473CrossRefPubMedPubMedCentral
20.
go back to reference Giustina A, Bonadonna S, Bugari G, Colao A, Cozzi R, Cannavo S, de Marinis L, Degli Uberti E, Bogazzi F, Mazziotti G, Minuto F, Montini M, Ghigo E (2009) High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. Eur J Endocrinol 161:331–338CrossRefPubMed Giustina A, Bonadonna S, Bugari G, Colao A, Cozzi R, Cannavo S, de Marinis L, Degli Uberti E, Bogazzi F, Mazziotti G, Minuto F, Montini M, Ghigo E (2009) High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. Eur J Endocrinol 161:331–338CrossRefPubMed
21.
go back to reference Giustina A, Mazziotti G, Cannavò S, Castello R, Arnaldi G, Bugari G, Cozzi R, Ferone D, Formenti AM, Gatti E, Grottoli S, Maffei P, Maffezzoni F, Montini M, Terzolo M, Ghigo E (2017) High-dose and high-frequency lanreotide autogel in acromegaly: a randomized, multicenter study. J Clin Endocrinol Metab. ;102(7):2454–2464. https://doi.org/10.1210/jc.2017-00142. PMID: 28419317 Giustina A, Mazziotti G, Cannavò S, Castello R, Arnaldi G, Bugari G, Cozzi R, Ferone D, Formenti AM, Gatti E, Grottoli S, Maffei P, Maffezzoni F, Montini M, Terzolo M, Ghigo E (2017) High-dose and high-frequency lanreotide autogel in acromegaly: a randomized, multicenter study. J Clin Endocrinol Metab. ;102(7):2454–2464. https://​doi.​org/​10.​1210/​jc.​2017-00142. PMID: 28419317
26.
27.
go back to reference Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Acromegaly Consensus Group (2023) Consensus on criteria for acromegaly diagnosis and remission. Pituit. https://doi.org/10.1007/s11102-023-01360-1. Epub ahead of print. Erratum in: Pituitary. 2023;: PMID: 37923946. Giustina A, Biermasz N, Casanueva FF, Fleseriu M, Mortini P, Strasburger C, van der Lely AJ, Wass J, Melmed S, Acromegaly Consensus Group (2023) Consensus on criteria for acromegaly diagnosis and remission. Pituit. https://​doi.​org/​10.​1007/​s11102-023-01360-1. Epub ahead of print. Erratum in: Pituitary. 2023;: PMID: 37923946.
28.
30.
go back to reference Mazziotti G, Biagioli E, Maffezzoni F, Spinello M, Serra V, Maroldi R, Floriani I, Giustina A (2015) Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab 100(2):384 – 394. https://doi.org/10.1210/jc.2014-2937. Epub 2014 Nov 3. PMID: 25365312 Mazziotti G, Biagioli E, Maffezzoni F, Spinello M, Serra V, Maroldi R, Floriani I, Giustina A (2015) Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis. J Clin Endocrinol Metab 100(2):384 – 394. https://​doi.​org/​10.​1210/​jc.​2014-2937. Epub 2014 Nov 3. PMID: 25365312
31.
go back to reference Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, Casanueva FF, Heaney AP, Biermasz N, Strasburger C, Melmed S (2019) A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement. Pituitary 22(6):569–573. https://doi.org/10.1007/s11102-019-00988-2. PMID: 31571098 Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, Casanueva FF, Heaney AP, Biermasz N, Strasburger C, Melmed S (2019) A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement. Pituitary 22(6):569–573. https://​doi.​org/​10.​1007/​s11102-019-00988-2. PMID: 31571098
32.
go back to reference Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, Casanueva FF, Heaney AP, Biermasz N, Strasburger C, Melmed S (2020) The tale in evolution: clarity, consistency and consultation, not contradiction and confusion. Pituitary 23(4):476–477. https://doi.org/10.1007/s11102-019-01027-w. PMID: 31912348 Ho KKY, Fleseriu M, Wass J, van der Lely A, Barkan A, Giustina A, Casanueva FF, Heaney AP, Biermasz N, Strasburger C, Melmed S (2020) The tale in evolution: clarity, consistency and consultation, not contradiction and confusion. Pituitary 23(4):476–477. https://​doi.​org/​10.​1007/​s11102-019-01027-w. PMID: 31912348
Metadata
Title
Pituitary: hic manebimus optime
Author
Andrea Giustina
Publication date
03-01-2024
Publisher
Springer US
Published in
Pituitary / Issue 1/2024
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-023-01379-4

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more